Kyoko Fujimoto1, An Smith1,2, Leonardo M Angelone1, Vikansha Dwivedi1, Sunder S Rajan1, Brent L Showalter1, and Nicole LL McMinn1
1Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, United States, 2University of Virginia, Charlottesville, VA, United States
Synopsis
Implantable medical devices marketed in the US may include MRI Safety
Information, to allow patients with such devices to safely undergo MR scans. However,
some implantable devices are not evaluated for MR compatibility due to constraints
of the testing cost and other resources. Not having MRI Safety Information in labeling
limits patients’ access to MR scans. This study aimed to perform a
retrospective analysis of MR safety testing data included in previously cleared
510(k) submissions for implantable orthopedic devices, with the goal to generate
datasets that may help establish guidelines that potentially reduce the regulatory
burden for future pre-market submissions.
INTRODUCTION
A Magnetic
Resonance Imaging (MRI) scanner is considered a non-significant risk device if
operated within specified parameters. Yet there are some safety concerns,
including radio-frequency (RF) thermal injury, especially for patients with
implantable devices. For simple,
elongated devices, such as stents or rods, the RF induced heating is directly
correlated with the length of the devices as previously shown with measurement
data1; however, predicting heating of implantable devices with more intricate
geometrical structures and sizes (e.g., complex orthopedic devices) can be
challenging without appropriate testing.
Medical
device manufacturers perform Magnetic Resonance (MR) compatibility testing based
on Standards2-6 and suggest either MR Safe, MR Conditional, or MR Unsafe
labeling in premarket submissions to US Food and Drug Administration. The
number of orthopedic devices with MR Conditional labeling has increased
steadily over the past decade; however, testing is still limited by constraints
related to cost and other resources including testing tools. As a result, some
devices have a label of “MR Not Evaluated”, which limits patients’ access to MRI.
This retrospective analysis of RF safety of implantable devices may help the
manufacturers to estimate RF induced-heating of the devices. In this study we
mined bench-testing measurements and computational modeling data from
previously cleared 510(k) submissions in orthopedic passive implantable devices. METHODS
Data mining was performed on 510(k) submissions for orthopedic
devices cleared from January 2014 to June 30, 2019. The following information
was gathered: locations of the device in clinical settings (“therapeutic
location”), RF safety test type (ASTM phantom measurement, ASTM phantom modeling
and anatomical human modeling), device dimensions, types of device components, and
temperature increase results. All the temperature results due to RF heating were
scaled to whole-body specific absorption rate (SAR) of 2 W/kg and were measured
over a scan period of 15 minutes3.
Based on the collected data, relationships between reported
worst-case temperature increases and device dimensions were analyzed for the
field strengths of 1.5T and 3.0T. Most
of the submissions included multiple sizes of devices; thus, there were more
data points than the number of the submissions. The analysis was focused on
submissions that included both measurement and computational modeling data with
the ASTM phantom.RESULTS
A total of 214 submissions were identified with MR Conditional
labeling. The number of submissions cleared with MR Conditional labeling has
been increasing over six years (Fig.1). The number of submissions in 2018 was
almost equal to the number of submissions from January to June in 2019. The submissions were then categorized in 12
therapeutic locations (Fig.2). Some devices targeted multiple therapeutic
locations.
The spine submissions were further analyzed as it was most common
(28%) in the orthopedic devices. There were 23 submissions which included testing
of both measurements and modeling using the ASTM phantom out of the spine
submissions. Five submissions included the results from modeling utilizing an
anatomical human model to demonstrate potential induced heating at the
therapeutic location. There were up to 88 total data points from this subset of
data: 40 for measurement, 27 for ASTM phantom modeling, and 21 for anatomical
human modeling. The reported uncertainty was around 25%. The device
components included rods, screws, plates, or cages, which were made of
titanium, titanium-alloy and/or polymers.
Reported temperature increases at 1.5T and 3.0T are summarized in
Figure 3. Average increases in temperature were 7.5°C ± 4.4°C at 1.5T and 5.3°C
± 3.2°C at 3.0T for ASTM phantom measurement, 6.9°C ± 4.1°C at 1.5T and 4.9°C ±
2.4°C at 3.0T for ASTM phantom modeling, and 3.3°C ± 2.2°C at 1.5T and 3.6°C ±
1.9°C at 3.0T for anatomical human modeling.
Device lengths and temperature increases from
measurement results were compared (Fig.4). The distribution suggests that the
relationship between temperature increase and device length depends on the
field strengths. DISCUSSION
Within data of submissions for spine devices, ASTM phantom measurement
results reported higher temperature increases at both field strengths compared
to that of computational modeling with ASTM phantom or anatomical human models.
However, this may not be the case for devices which are implanted at multiple
therapeutic locations such as small bone implantable devices. For such devices,
modeling results with anatomical human models may reveal higher temperature
increase than those of measurement with ASTM.
Variability in temperature data may have been impacted by the
variability in device dimensions other than length. Furthermore, challenges
faced in the development of this database include a lack of information
regarding certain detailed parameters. Future studies include devices for
different therapeutic locations, detailed dimensions including width and
diameter and, the orientation of the device on the anatomy of the body as they
can also contribute to RF-induced heating in addition to lengths. CONCLUSION
MR RF heating retrospective analysis was performed on 214 cleared
510(k) orthopedic submissions with a focus on spinal implantable devices. Comparisons
of measurement and modeling data revealed that ASTM phantom measurement data estimates
higher temperature increase for spine implantable devices. More rigorous analyses for other therapeutic
locations may help the orthopedic device manufacturers for MR conditional labeling.Acknowledgements
DISCLAIMER: The mention of commercial products, their sources, or their use in
connection with material reported herein is not to be construed as either an
actual or implied endorsement of such products by the Department of Health and
Human Services.References
- Song T, Xu Z, Iacono MI, et al. Retrospective
analysis of RF heating measurements of passive medical implants. Magn. Reson.
Med. 2018;80(6):2726-2730.
- ASTM F2053 – 13 Standard Practice for Marking
Medical Devices and Other Items for Safety in the Magnetic Resonance
Environment. ASTM International, West Conshohocken, PA, 2013, DOI:
10.1520/F2503-13, www.astm.org
- ASTM F2182 – 11a Standard Test Method for
Measurement of Radio Frequency Induced Heating On or Near Passive Implants
During Magnetic Resonance Imaging. ASTM International, West Conshohocken, PA,
2011, DOI: 10.1520/F2182-11A, www.astm.org
- ASTM F2052 – 14 Standard Test Method for
Measurement of Magnetically Induced Displacement Force on Medical Devices in
the Magnetic Resonance Environment. ASTM International, West Conshohocken, PA,
2014, DOI: 10.1520/F2052-14, www.astm.org
- ASTM F2119 – 07 Standard Test Method for
Evaluation of MR Image Artifacts from Passive Implants. ASTM International,
West Conshohocken, PA, 2013, DOI: 10.1520/F2119-07, www.astm.org
- ASTM F2213 – 17 Standard Test Method for
Measurement of Magnetically Induced Torque on Medical Devices in the Magnetic
Resonance Environment. ASTM International, West Conshohocken, PA, 2013, DOI:
10.1520/F2213-17, www.astm.org